JONBUR Research · Initiation
Techwing · 089030 · Machinery
Techwing: Sharp Share Price Rebound Alongside Mixed Earnings and Negative Trailing Net Income
Why this report
Start of coverage: one of the 300 largest companies, written once its financial statements were in.
Techwing, a KOSDAQ-listed machinery company, closed at ₩54,500 on 2026-10-12, up 17.6% in one month and 24.3% over three months but down 11.8% over one year. Trailing operating profit is positive at ₩29.9B, yet trailing net income is a loss of ₩11.7B and free cash flow is negative.
Written Oct 13, 2026 · Data as of Oct 12, 2026 · 0 views
This is not financial advice. The report does not recommend buying or selling anything.
Thesis
The data supports a recovery in operating profit: the trailing operating margin of 16.2% is above the 10.0% of 2025 and 12.6% of 2024. Filings also show a steady stream of major sales or supply contract reports between July and September 2026, which fits with improving operations, although the filing titles carry no contract values.
What the data does not support is a clean earnings picture. Trailing net income is -₩11.7B, ROE is -5.9% and free cash flow is -₩28.2B. Valuation is demanding on the metrics available, with price-to-book at 9.7 and price-to-sales at 11.0. The price is ₩54,500 against a 52-week range of ₩31,625 to ₩74,000, so it is well off the high but far above the low. No model fair value could be worked out, and no news headlines, investor flow, foreign ownership or short balance data are available.
Business overview
Techwing (테크윙, code 089030) is listed on KOSDAQ and classified in the data under Machinery. It was founded on 2002-08-01 and listed on 2011-11-10. The data names co-CEOs 나윤성 and 장 남. There are 37,353,645 listed shares, and the market capitalisation is about ₩2.04T, with enterprise value of about ₩2.10T.
The revenue history is volatile: ₩255.9B in 2021, ₩267.5B in 2022, ₩133.6B in 2023, ₩185.5B in 2024 and ₩159.1B in 2025. The data does not describe products or customers.
Financial analysis
All figures below come from filed financial statements (DART).
Revenue growth swung from +4.5% in 2022 to -50.1% in 2023, +38.8% in 2024 and -14.2% in 2025. Operating margin moved from 21.6% in 2022 to 2.4% in 2023, 12.6% in 2024 and 10.0% in 2025. Net income was ₩32.6B in 2022, then losses of ₩9.3B in 2023 and ₩20.9B in 2024, and a profit of ₩9.4B in 2025 (ROE 4.6%).
Over the trailing twelve months to H1 2026, revenue was ₩184.8B, operating income ₩29.9B (16.2% margin) and net income -₩11.7B (-6.3% margin), with ROE of -5.9%. The gap between operating profit and net loss is not explained in the data.
The balance sheet shows cash of ₩61.9B against borrowings of ₩125.8B. Liabilities to equity is 213.9%. Free cash flow over the period is -₩28.2B.
Valuation
A price-to-earnings ratio is not available because trailing earnings are negative, and EV/EBITDA is also unavailable. Price-to-book is 9.7 and price-to-sales is 11.0. The dividend yield is 0.2%. At the end of 2025 the P/E was 182 and the P/B was 8.0, so the book multiple is now higher than at that point. Earlier year-end multiples are not available.
Peers show wide dispersion: P/B of 5.6 for Doosan Enerbility, 32.1 for Hanmi Semiconductor, 20.2 for Jusung Engineering, 57.1 for Rainbow Robotics and 6.0 for Wonik IPS. Techwing's 9.7 sits within that range. Peer P/E ratios are mostly very high (37.1 to 4,456.7), so they offer little useful anchor.
Our simple 5-year discounted cash flow model could not produce a fair value range (bear, base and bull are all unavailable), largely because free cash flow is negative. There is therefore no model value to compare with the ₩54,500 share price.
Catalysts
- Repeated filings of major sales or supply contracts (2026-07-20, 08-10, 09-29, plus amendments) may signal order activity, though contract sizes are not shown in the data.
- The H1 2026 half-year report, filed 2026-08-14, showed a trailing operating margin of 16.2%, the highest since 2022.
- Several 5%+ holding reports (07-31, 08-24, 09-07, 09-29) point to changes in major shareholdings.
- A filing in August 2026 on the sale of property, plant and equipment could affect cash and asset positions, though details are not in the data.
- The share price has risen 17.6% over one month and 24.3% over three months, showing improved market sentiment.
Risks
- Trailing net income is -₩11.7B despite positive operating income, so profit is not reaching shareholders.
- Free cash flow is -₩28.2B and borrowings of ₩125.8B exceed cash of ₩61.9B, with liabilities to equity at 213.9%.
- Revenue has been highly cyclical, including a 50.1% fall in 2023, which makes earnings hard to forecast.
- Valuation multiples (P/B 9.7, P/S 11.0) are high relative to current returns, leaving little room if results disappoint.
- Investor flow, foreign ownership, short balance and news data are unavailable, which limits the view on market positioning.
Closing view
The evidence is mixed. Operating profit and contract-related filings point to better business momentum, and the share price has rebounded over recent months. Against that, trailing net income and free cash flow are negative, leverage is high and valuation multiples are elevated, with no model fair value available for comparison. The data does not settle whether the operating recovery will carry through to net profit and cash generation, and several positioning indicators are missing.
Model estimate of fair value
The valuation model has no estimate for this company yet (not enough data, or no positive value with the base case).
Filings and data used
- Amended: Major sales or supply contractSep 29, 2026
- 5%+ holding reportSep 29, 2026
- 5%+ holding reportSep 7, 2026
- Amended attachment: Sale of property, plant and equipmentAug 31, 2026
- 5%+ holding reportAug 24, 2026
- Added attachment: Half-year report (Jun 2026)Aug 14, 2026
- Amended: Major sales or supply contractAug 13, 2026
- Major sales or supply contractAug 10, 2026
- Amended: Major sales or supply contractAug 4, 2026
- 5%+ holding reportJul 31, 2026
- Major sales or supply contractJul 20, 2026
- Preliminary earnings (consolidated)Jul 13, 2026
- Daily prices up to 2026-10-12
- Financial statements, trailing 12 months as of H1 2026
Report history
Source: KRX statistical information